BioSpace News Archive

TraceLink Inc. announced its Russia compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all pharmaceutical manufacturers that supply medicines to the Russian market, in advance of the country’s December 2019 enforcement deadline.

Stellar Biotechnologies, Inc. reported financial results for the three and nine months ended June 30, 2018 and provided an update on its business.

Scholarships Awarded to Nine Students Affected by Dermatologic Conditions

ACG Inspection (ACGI) has partnered with CertiRx Corporation, d.b.a. “Verinetics” for further enhancing its Traceability and Authenticity solutions in the Track and Trace industry.

OncoPep, Inc. today announced the initiation of a Phase 1b clinical trial evaluating the safety and tolerability of PVX-410.

Trial to Evaluate the Combination of Rubraca® (rucaparib) and OPDIVO® (nivolumab) in Patients with Advanced Ovarian Cancer.

Mylan N.V. announced its financial results for the quarter and six months ended June 30, 2018.

BioStem Technologies, Inc. has announced that it has implemented an expanded shareholder communications initiative to provide improved clarity into BioStem’s business plans, upcoming research and development, drug approvals and growth strategy.

Lenabasum has reached Phase 3 clinical stage in two orphan autoimmune indications: systemic sclerosis and dermatomyositis, affecting up to 200,000 patients in the USA, EU and Japan

Prolific inventor, serial entrepreneur and creator of the RaniPill™ capsule recognized for unbridled curiosity and passion for solving difficult problems